We searched PubMed, Medline, and Cochrane databases with English keywords “psoriasis”, “HIV”, “psoriatic arthritis”, “pathogenesis”, “treatment”, “clinical features”, and “diagnosis”. We reviewed the reference lists of all articles retrieved, together with those in our personal reference libraries. An updated search was done on April 16, 2010.
ReviewHIV-associated psoriasis: pathogenesis, clinical features, and management
Introduction
The Joint UN Programme on HIV/AIDS and WHO reported that there were 33·4 million people with HIV infection worldwide in 2008;1 sub-Saharan Africa accounts for 67% of this number. According to the UK Health Protection Agency, there are 77 400 individuals infected with HIV in the UK.2
The immune dysfunction associated with HIV results in several cutaneous disorders, with progressive immunocompromise resulting in AIDS. Dermatological disorders such as psoriasis can be the presenting feature of HIV infection and can provide clinical clues to the degree of immune dysfunction. In this Review, we discuss the pathogenesis, clinical features, and management of psoriasis with HIV.
Section snippets
Classic psoriasis
Psoriasis is a chronic inflammatory skin disease and is prevalent in 1–2% of northern European populations.3 The common phenotype, psoriasis vulgaris, is characterised by symmetrical, erythematosus, scaly plaques typically found on the extensor surfaces of the skin although any site can be affected. Concomitant psoriatic arthritis happens in 5–42% of patients.4 Histologically, psoriasis is characterised by amplified proliferation of basal keratinocytes, a thickened epidermis, premature
HIV and psoriasis
The prevalence of HIV-associated psoriasis and HIV-associated psoriatic arthritis may or may not be the same as in the general population.23, 24, 25, 26, 27, 28 Psoriasis might worsen or be detected for the first time with HIV. It can be very severe, but can regress before death.23, 29 The development of HIV-associated psoriasis and HIV-associated psoriatic arthritis might be associated with poor prognosis in untreated patients, with a mean expectancy ranging from 4 months to 24 months after
Pathogenesis
Although psoriasis can present throughout the range of immunodeficiency, it tends typically to present late with increasing immunodysfunction,26 and CD4-cell counts are less than 100 cells per μL in many patients.24 This finding is paradoxical since the pathogenesis of psoriasis is associated with the activation of T cells and treatments that decrease T-cell counts improve psoriasis.33 Contributing to the paradox is that psoriasis is characterised by T cells that produce type-1 cytokines
Clinical features
The classic signs of plaque psoriasis are symmetrical erythematous (so-called salmon pink) patches or plaques with silver scales. Nail signs include coarse pitting, onycholysis, subungual hyperkeratosis, splinter haemorrhages, and frank onychodystrophy. A yellow subungual discolouration due to nail bed involvement (oil-drop lesion) is the only specific sign of nail psoriasis. Care must be taken to exclude onychomycosis (also common in HIV) since the clinical features can be similar to nail
Differential diagnosis
Annular psoriasis might be confused with ringworm; skin scrapings for fungal microscopy and culture help distinguish the latter. Microscopy can also be helpful to exclude crusted (Norwegian) scabies, to which patients with HIV are prone and which is highly contagious if undiagnosed. The clinical presentation can mimic psoriasis since the lesions are often non-pruritic and present as scaly plaques on the skin (figure 6), scalp, and nails.63
Papulosquamous secondary syphilis might clinically and
Histology and treatment
The histological features of HIV-associated psoriasis might be identical to classic psoriasis; however, diagnosis might be difficult. A psoriasiform dermatitis with few neutrophilic microabscesses, irregular acanthosis, and a perivascular infiltrate of lymphocytes, macrophages, and multinucleated giant cells might be seen.24, 65 Typically in HIV-associated psoriasis, there are few T cells, dyskeratotic keratinocytes, and lymphocytoclasis; but plasma cells are common. Since plasma cells are
Conclusions
The immunological dysfunction associated with HIV creates an environment that is conducive to developing psoriasis in those individuals constitutively susceptible by virtue of their immunogenotype. The main postulated mechanisms are a T-cell imbalance characterised by decreased CD4 T cells and a relative increase in CD8 memory T cells, a cytokine milieu predominantly mediated by interferon γ, superantigen stimulation of autoimmunity by HIV or other viral and bacterial infections and HLA Cw0602
Search strategy and selection criteria
References (111)
Psoriasis
Lancet
(2003)- et al.
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression
Trends Immunol
(2004) - et al.
Pathogenesis and clinical features of psoriasis
Lancet
(2007) - et al.
High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA
J Invest Dermatol
(1999) - et al.
Psoriasis regression in terminal AIDS
Lancet
(1992) - et al.
Remission of AIDS-associated psoriasis with zidovudine
Lancet
(1987) - et al.
Psoriasis and human immunodeficiency virus infection
J Am Acad Dermatol
(1992) - et al.
Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection
Rheum Dis Clin North Am
(1991) - et al.
Autoreactivity in HIV-1 infection: the role of molecular mimicry
Clin Immunol Immunopathol
(1995) - et al.
Identification of an HIV-1 Nef peptide that binds to HLA class II antigens
Biochem Biophys Res Commun
(1994)
A potential role for superantigens in the pathogenesis of psoriasis
J Invest Dermatol
Immunopathogenesis and role of T cells in psoriasis
Clin Dermatol
TH17 cells and regulatory T cells in primary immunodeficiency diseases
J Allergy Clin Immunol
Superantigens, autoantigens, and pathogenic T cells in psoriasis
J Invest Dermatol
Escape from “horror autotoxicus”: pathogenesis and treatment of autoimmune disease
Cell
Bilateral panuveitis, sebopsoriasis, and secondary syphilis in a patient with acquired immunodeficiency syndrome
Am J Ophthalmol
Reactive arthritis and associated arthritides
Rheum Dis Clin North Am
Papulosquamous dermatoses of AIDS
J Am Acad Dermatol
Current and future management of psoriasis
Lancet
Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy
J Am Acad Dermatol
The safety of UVB phototherapy in patients with HIV infection
J Am Acad Dermatol
UVB phototherapy is an effective treatment for pruritus in patients infected with HIV
J Am Acad Dermatol
Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience
J Am Acad Dermatol
Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment
J Invest Dermatol
The risk of melanoma in association with long-term exposure to PUVA
J Am Acad Dermatol
Cutaneous malignancy and human immunodeficiency virus disease
J Am Acad Dermatol
Psoriasis in patients with HIV infection: from the Medical Board of the National Psoriasis Foundation
J Am Acad Dermatol
The use of methotrexate for treatment of psoriasis in patients with HIV infection
J Am Acad Dermatol
Outcome of HIV infection in transplant patient on cyclosporin
Lancet
Use of cyclosporin for psoriasis in HIV-positive patient
Lancet
Zidovudine treatment of psoriasis associated with acquired immunodeficiency syndrome
J Am Acad Dermatol
Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine
Lancet
AIDS epidemic update 2009
HIV in the United Kingdom: 2008 report
The genetics of psoriasis, psoriatic arthritis and atopic dermatitis
Hum Mol Genet
Psoriatic arthritis
Expert Opin Investig Drugs
Pathogenesis and therapy of psoriasis
Nature
Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis
Hum Mol Genet
Getting under the skin: the immunogenetics of psoriasis
Nat Rev Immunol
Psoriasis and HLA-Cw6
Br J Dermatol
HLA-C and guttate psoriasis
Br J Dermatol
Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation
J Immunol
Angiogenesis drives psoriasis pathogenesis
Int J Exp Pathol
Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis
Br J Dermatol
Cross-reactivity between streptococcal M surface antigen and human skin
Br J Dermatol
Postherpetic erythema exsudativum multiforme with concomitant exacerbation of psoriasis vulgaris
Hautarzt
Psoriasis guttate acuta triggered by varicella zoster virus infection
Eur J Dermatol
A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression
Br J Dermatol
A high prevalence of parvovirus B19 DNA in patients with psoriasis
Arch Dermatol Res
A new endogenous retroviral sequence is expressed in skin of patients with psoriasis
Br J Dermatol
Cited by (132)
Infections in the era of immunobiologicals
2024, Anais Brasileiros de DermatologiaErythrodermic Psoriasis Following SARS-CoV-2 Infection
2024, Actas Dermo-SifiliograficasHIV: Inflammatory dermatoses
2024, Clinics in DermatologyUse of risankizumab in two HIV-positive patients with psoriasis
2023, JAAD Case ReportsHIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity
2023, Journal of Investigative Dermatology